ABVC BIOPHARMA, INC. quarterly report, Q1 FY2014

Filing identity and reporting period

The supplied filing is for Ecology Coatings, Inc., not ABVC Biopharma, Inc. It is a Form 10-Q for the quarter ended June 30, 2014, with results also reported for the nine months ended that date. The filing was signed April 17, 2015. Investors should verify the company and period before relying on this summary.

Financial results and condition

  • Revenue: $0 for both the three and nine months ended June 30, 2014, compared with $0 and $7,787, respectively, in 2013.
  • Loss: Net loss was $30 for the quarter and $70 for the nine months, versus $103,547 and $226,352 in the comparable 2013 periods. Basic and diluted loss per share was reported as $0.00 (rounded).
  • Expenses: Operating expenses were $30 for the quarter and $70 for the nine months, down from $19,373 and $185,046. No interest expense was reported in 2014; 2013 interest expense was $16,537 for the quarter and $49,093 for the nine months.
  • Cash flow and liquidity: Nine-month operating cash use was $70, with no investing or financing cash flows. Cash was $548 at June 30, 2014, down from $618 at September 30, 2013. The filing describes working-capital deficits and liabilities exceeding assets.
  • Balance sheet: Total assets were $231,899, including $192,864 of intangible assets. Liabilities subject to compromise were $2,112,143; shareholders’ deficit was $1,880,244. The filing does not provide a clear breakdown of debt maturities or current liabilities.

Material changes and unusual circumstances

Management attributed lower expenses and losses primarily to reduced insurance and compensation costs and the absence of interest expense during bankruptcy proceedings. The company reported no 2014 revenue. It stated that it filed for Chapter 7 bankruptcy protection in May 2013 and that, in September 2014, it emerged with its corporate shell as its only asset and liabilities settled; the September date was to serve as a fresh-start date for later financial statements.

The filing contains inconsistent descriptions of the bankruptcy timeline: it says the Chapter 7 filing occurred in 2013, but elsewhere describes a bankruptcy filing as subsequent to the June 2014 balance-sheet date. It also gives September 10 and September 19, 2014 as dates associated with debt settlement/emergence. The reported operating business is expressly described as no longer applicable after emergence.

Outlook, risks, and controls

No specific operating guidance or business outlook is provided. Management said new management had arranged small working-capital loans to support required filings while determining a future direction. The company warned that it might not be able to launch a new business plan or raise enough capital to meet filing requirements. It also cited risks involving commercialization, competition, intellectual property, capital, sales infrastructure, suppliers, manufacturing, and talent.

Management concluded disclosure controls were not effective, citing lack of segregation of duties because of a small financial staff. The filing states there were no material commitments or contingencies and no legal proceedings reported in the relevant sections. It also identifies a going-concern concern and says the financial statements do not include adjustments that might be needed if the company could not continue as a going concern.

Important facts for investors to verify

  • Confirm that this Ecology Coatings filing—not an ABVC Biopharma filing—is the intended document.
  • Verify the bankruptcy, debt-settlement, and emergence dates and the legal effect of the stated liability settlement.
  • Review subsequent filings for the fresh-start accounting, post-emergence ownership, assets, liabilities, and any new business plan or financing.
  • Assess the company’s very limited cash, lack of revenue, going-concern disclosure, and ineffective disclosure controls.
  • Check the filing’s late signature date and its inconsistent statements about the bankruptcy timeline.